In Brief: Product liability reform
This article was originally published in The Gray Sheet
Executive Summary
Product liability reform: Meeting between the staffers of Sens. Slade Gorton (R-Wash.) and John Rockefeller (D-W.Va.) and the White House to discuss a compromise on product liability legislation is expected to take place the week of Nov. 3. Compromise language negotiated by Rockefeller with the White House in September ("The Gray Sheet" Sept. 29, In Brief) reportedly has not been accepted by Republicans. In an Oct. 29 letter to President Clinton, 13 consumer organizations claim the legislation agreed to by Rockefeller and the White House would "have a catastrophic impact on millions of Americans"...
You may also be interested in...
Adalvo Hails First European Launch Of Prolonged-Release Pregabalin
After the drug’s approval for use in neuropathic pain within the EU last December, Adalvo announced the analgesic’s first European launch in Germany.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.